Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
24 4月 2017
First High Court judgment on FRAND royalties
24 3月 2017
Damages for pharmaceutical patent infringement: Federal Court gives long awaited guidance
23 3月 2017
UPC Preparatory Committee holds final meeting signalling readiness for the UPC's Provisional Application Phase and Germany passes bills necessary to ratify the UPC Agreement
10 3月 2017
25 Years of Class Actions in Australia
8 3月 2017
Helping FMCG Businesses plan for a Post-Brexit future
28 2月 2017
Staying focussed: the ACCC’s key priorities for 2017
18 1月 2017
Patent and Pharma Update - January 2017
23 12月 2016
Regulatory reform to the advertising of medicines and medical devices
22 12月 2016
Infringement of Patented Method Claims: The Need to Think Beyond Australia
8 12月 2016
Effective, orderly and expeditious IP litigation in the Federal Court of Australia
29 11月 2016
The UPC open for business in 2017? Announcement that UK will ratify UPC Agreement
28 10月 2016
Class action growth continues as 25th anniversary looms
